PUMA BIOTECHNOLOGY, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Los Angeles, CA
SEC filing record 1 source field available
Fiscal year end
31 December
PUMA BIOTECHNOLOGY, INC. has filed 1,115 SEC EDGAR filings since 14 Sep 2007

SEC filing history

Showing 326-350 of 1,000 matching filings.

Per page
25
Current page
14
SC 13G/A File 005-83367

PRIMARY DOCUMENT

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83367

SC 13G/A filing

Filing date
11 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83367

SCHEDULE 13G/A

Filing date
10 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83367

SC 13G/A filing

Filing date
10 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-83367

PUMA BIOTECHNOLOGY, INC.

Filing date
08 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Feb 2022
Reporting date
02 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Feb 2022
Reporting date
02 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Feb 2022
Reporting date
02 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83367

SC 13G/A filing

Filing date
03 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-83367

SC 13G filing

Filing date
14 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jan 2022
Reporting date
03 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jan 2022
Reporting date
03 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jan 2022
Reporting date
03 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jan 2022
Reporting date
03 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Dec 2021
Reporting date
02 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 - WONG

Filing date
06 Dec 2021
Reporting date
02 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Dec 2021
Reporting date
02 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 AUERBACH

Filing date
06 Dec 2021
Reporting date
02 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-83367

SC 13G filing

Filing date
19 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83367

PUMA BIOTECHNOLOGY, INC.

Filing date
10 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-257687

FORM 424B5

Filing date
04 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .